Mon Jan 14, 2013 1:59pm EST

LOS ANGELES, CA, Jan 14 (Marketwire) --

CompuMed, Inc. (PINKSHEETS: CMPD) (www.compumed.net) -- a leader in
telemedicine services for patient diagnosis and management -- announced a
change in management. Effective December 31, 2012, Maurizio Vecchione
resigned from his position as CEO in order to become Vice President of
Global Good at Intellectual Ventures. Global Good is a collaborative
effort between Intellectual Ventures and Bill Gates to tackle humanity's
problems through new inventions and technologies, with a focus on the
developing world. Mr. Vecchione will remain a member of CompuMed's Board
of Directors.

Also effective December 31, 2012, W. Scott Rombach, in addition to his
responsibilities as President, assumed the CEO role. "Scott's expertise
in driving global enterprise transactions and developing strategic
partnerships is a tremendous asset to CompuMed. He has a unique skill set
and is the right individual to take the company to the next level," said
Maurizio Vecchione.

Mr. Rombach has served on the Board of Directors of CompuMed since 2011.
He was appointed President in October of 2012.

As a sales executive with PeopleSoft, Inc., Mr. Rombach specialized in
executing large software and services deals. He brings a deep
understanding of how customers can best leverage enterprise technology
solutions to cut costs and drive revenue. Prior to its acquisition by
Oracle, PeopleSoft was the global leader in providing enterprise human
resources and payroll software solutions. Mr. Rombach also has experience
in a start-up environment. With Armstrong Laing, he drove sales that
helped this UK based company to become one of the market leaders in
Activity Based Management (ABM) software solutions. Mr. Rombach has an
M.B.A. from Georgia State University and a B.A. in Marketing from
Michigan State University.

"We are very grateful for the contributions Maurizio has made to the
company and are glad that he will continue to serve on the board. The
board feels that the company is in good hands with Scott Rombach as its
leader," said Mr. Mark Stolper, CompuMed's Chairman.

About CompuMed
CompuMed's diagnostic and management tools for the
healthcare community focus on telecardiology systems and software
solutions. We offer analysis and remote monitoring for patients with
cardiovascular and musculoskeletal diseases designed to improve
healthcare provider workflow and patient care while reducing costs.
CompuMed is headquartered in Los Angeles and distributes its products
worldwide both directly and through OEM partners. Visit CompuMed at
www.compumed.net and follow on Twitter @compumed.

Forward-Looking Statements
Statements contained in this report, such as
statements about revenue, operations, and earnings growth and other
financial results are forward-looking statements pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of
1995. All such forward-looking statements including statements concerning
the Company's plans, objectives, expectations and intentions are based
largely on management's expectations and are subject to and qualified by
risks and uncertainties that could cause actual results to differ
materially from those expressed or implied by such statements. These
statements are subject to uncertainties and risks including, without
limitation, product and service demand and acceptance, changes in
technology, ability to raise capital, the availability of appropriate
acquisition candidates and/or business partnerships, economic conditions,
the impact of competition and pricing, capacity and supply constraints or
difficulties, government regulation and other risks identified in the
Company's filings with the Securities and Exchange Commission and OTC
Pink operated by OTC Markets. All such forward-looking statements are
expressly qualified by these cautionary statements. The Company expressly
disclaims any obligation or undertaking to release publicly any updates
or revisions to any forward-looking statements to reflect events,
conditions or circumstances on which any such statement is based after
the date hereof, except as required by law.

Press Contact:
Susan Tellem
Tellem Grody Public Relations
+1 310-313-3444
susan@tellemgrodypr.com

Copyright 2013, Marketwire, All rights reserved.

distributed by